The firm's existing stakeholder taxonomy recognized four classes: patients, payers, providers, and regulators. Working with the CFO's office, the audit committee, and the chief compliance officer, our hypothesis going in was that material value was being produced through interactions with a fifth class — characterizable as adjacent participants — for which no recognition framework existed and therefore no measurement existed.
Our task was twofold: first, to confirm or disprove the hypothesis at a level the audit committee could rely on; second, to propose a recognition framework that the firm's external auditors would accept under existing standards.